Related Experiment Video
Updated: Sep 11, 2025

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
Geographic Variation in the Utilization of Cancer Care From Subspecialized Medical Oncologists in the United States,
René Karadakic1, Christopher Manz2, Arno Cai1
1Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, Massachusetts (R.K., A.C.).
Background:
The growing complexity of cancer care may be driving an increase in subspecialized medical oncologists who focus on treating specific cancer types. However, little is known about trends in subspecialization among oncologists and differences in utilization of subspecialists.
Objective:
To quantify trends in oncologist subspecialization and assess differences in utilization of subspecialized cancer care in the United States.
Design:
Retrospective cohort study using Medicare claims data from 2007 to 2021.
Setting:
National, fee-for-service Medicare.
Participants:
Medicare beneficiaries initiating chemotherapy between 2008 and 2020.
Measurements:
Chemotherapy episodes were defined using methods from the Oncology Care Model. Subspecialization was identified based on whether oncologists managed more than 80% of chemotherapy episodes within a single cancer category. Outcomes included the annual share of oncologists classified as subspecialists, and the share of chemotherapy episodes managed by these oncologists, stratified by cancer type, geography, and socioeconomic characteristics.
Results:
Among 18 633 oncologists and 9.25 million chemotherapy episodes, the proportion of episodes managed by subspecialists increased from 9% in 2008 to 18% in 2020. Utilization varied widely across cancer types and regions, with the highest levels observed in large metropolitan areas. Differences by income widened over time: in 2020, 27.6% of episodes in the highest-income counties were managed by subspecialists, compared with only 8.8% in the lowest-income counties, despite higher cancer mortality in the latter.
Limitations:
Analyses were limited to fee-for-service Medicare beneficiaries and excluded patients treated with surgery or radiation alone. Subspecialization was defined using practice patterns rather than formal training, and the study does not assess patient outcomes or causal effects.
Conclusion:
Subspecialization in oncology is increasing but is unevenly distributed, with growing differences in utilization across income groups and regions.
Primary Funding Source:
National Institute on Aging.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
Related Concept Videos
Cancer Survival Analysis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...